Deutsche Bank AG Has $1.44 Million Position in Surgery Partners, Inc. $SGRY

Key Points

• Deutsche Bank AG has reduced its stake in Surgery Partners, Inc. by 37.3%, now holding 60,556 shares worth approximately $1.44 million after selling 35,956 shares.
• Surgery Partners reported a quarterly EPS of $0.17, exceeding analysts' expectations, with revenues of $826.20 million, reflecting an 8.4% year-over-year increase.
• Analysts maintain a consensus rating of "Moderate Buy" on Surgery Partners stock, with an average price target of $33.00, despite varying ratings from institutions like Bank of America and Barclays.

Deutsche Bank AG trimmed its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 37.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,556 shares of the company's stock after selling 35,956 shares during the period. Deutsche Bank AG's holdings in Surgery Partners were worth $1,438,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Janus Henderson Group PLC raised its stake in shares of Surgery Partners by 110.2% in the 4th quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock valued at $244,616,000 after purchasing an additional 6,057,477 shares in the last quarter. King Street Capital Management L.P. increased its stake in shares of Surgery Partners by 93.1% in the fourth quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock valued at $59,276,000 after purchasing an additional 1,350,000 shares during the period. Point72 Asset Management L.P. increased its stake in shares of Surgery Partners by 224.7% in the fourth quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock valued at $36,975,000 after purchasing an additional 1,208,639 shares during the period. Alpine Associates Management Inc. bought a new position in shares of Surgery Partners in the first quarter valued at approximately $13,539,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Surgery Partners by 18.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock valued at $75,739,000 after acquiring an additional 563,812 shares in the last quarter.

Surgery Partners Stock Performance

NASDAQ SGRY traded down $0.10 during midday trading on Thursday, hitting $22.72. The company had a trading volume of 1,109,822 shares, compared to its average volume of 1,695,299. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of -15.89 and a beta of 1.82. The firm has a fifty day simple moving average of $22.29 and a two-hundred day simple moving average of $22.83. Surgery Partners, Inc. has a fifty-two week low of $18.87 and a fifty-two week high of $33.90.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. During the same period in the previous year, the business earned $0.21 EPS. The firm's revenue was up 8.4% on a year-over-year basis. Equities analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the sale, the director directly owned 45,173 shares in the company, valued at approximately $1,027,234.02. The trade was a 30.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Barclays cut their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a "buy" rating and a $28.00 price target on the stock. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.